Second, the absence of heavy mutagenic exposure yields a comparatively low tumour-mutational burden, reinforcing ‘oncogene addiction’ to mutant EGFR and prolonging sensitivity to potent third-generation inhibitors (Rudin et al., 2009). Here, EGFR is linked to neoplasm.